Specialty Pharmacy

Regular physical activity is effective lowering the risk of diabetes, but some patients do not see improved insulin sensitivity.

Researchers establish new criteria to diagnose functional gastrointestinal disorders.

Top news of the day from across the health care landscape.

Discovery may lead to new treatments for colon cancer.

New analysis may lead to the development of new antiviral HIV drugs.

Surgeons were able to remove 29% of additional tumors using OTL38.

US cancer centers spent $173 million on advertising in 2014.

Avelumab is an experimental, full human anti-PD-L1 Ig G1 monoclonal antibody.

Levels of good and bad gut bacteria influences autoimmune disease.

Tenofovir disoproxil fumarate and emtricitabine administered via a sustained release intravaginal ring shows promise treating (S)HIV.

Top news of the day from across the health care landscape.

Mole rats are remarkably resistant to cancer.

UM-164 blocks the c-Src kinase that plays a role in the growth and spread of breast cancer.

Positive relationship found between the pricing of HCV drug regimens with the rate of sustained viral response.

The evolocumab (Repatha) Pushtronex system is the first to offer a monthly single-dose delivery option.

Sutent is an oral multi-kinase inhibitor originally approved by the FDA in 2006.

Josh Stein, CEO and co-founder of AdhereTech, discusses how technology can enhance the ability of specialty pharmacies to manage their patients' therapy regimen.

Study finds disparities in cancer survival independent of socioeconomic status.

CD40-antibody drugs could have enhanced anti-tumor activity.

Top news from across the health care landscape.

Drug efficacy varies in colorectal cancer dependent on where the tumor is located.

Specialty drugs accounted for nearly half of total drug spending from just 1.8% of total prescriptions filled.

Four major hepatitis genotypes kill more people than HIV, malaria, and tuberculosis.

Humulin R U-500 has been approved since 1994 for the treatment of diabetes, but a dedicated syringe did not previously exist.

Study reveals untapped potential of gene-editing tool.

Top news of the day from across the health care landscape.

Certain bacterial populations are increased or decreased in the presence of cancer.

A majority of patients with specific gene mutation will eventually relapse and die of treatment-resistant leukemia.